nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP2B6—Thiotepa—urinary bladder cancer	0.154	0.358	CbGbCtD
Voriconazole—PTGS1—Etoposide—urinary bladder cancer	0.0548	0.127	CbGbCtD
Voriconazole—CYP3A4—Thiotepa—urinary bladder cancer	0.0473	0.11	CbGbCtD
Voriconazole—CYP2B6—Cisplatin—urinary bladder cancer	0.0425	0.0987	CbGbCtD
Voriconazole—CYP3A5—Etoposide—urinary bladder cancer	0.0329	0.0764	CbGbCtD
Voriconazole—CYP2B6—Doxorubicin—urinary bladder cancer	0.0285	0.0662	CbGbCtD
Voriconazole—CYP2C9—Fluorouracil—urinary bladder cancer	0.0264	0.0614	CbGbCtD
Voriconazole—CYP2C9—Cisplatin—urinary bladder cancer	0.0224	0.0522	CbGbCtD
Voriconazole—FMO3—urine—urinary bladder cancer	0.0129	0.187	CbGeAlD
Voriconazole—CYP3A4—Etoposide—urinary bladder cancer	0.0128	0.0298	CbGbCtD
Voriconazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.00875	0.0203	CbGbCtD
Voriconazole—CYP2C19—urine—urinary bladder cancer	0.00569	0.0825	CbGeAlD
Voriconazole—FMO1—prostate gland—urinary bladder cancer	0.00534	0.0776	CbGeAlD
Voriconazole—FMO3—prostate gland—urinary bladder cancer	0.00462	0.067	CbGeAlD
Voriconazole—CYP2C9—urine—urinary bladder cancer	0.00441	0.064	CbGeAlD
Voriconazole—FMO1—renal system—urinary bladder cancer	0.00364	0.0529	CbGeAlD
Voriconazole—FMO1—urethra—urinary bladder cancer	0.00358	0.0519	CbGeAlD
Voriconazole—CYP3A4—urine—urinary bladder cancer	0.00336	0.0488	CbGeAlD
Voriconazole—FMO1—vagina—urinary bladder cancer	0.00264	0.0383	CbGeAlD
Voriconazole—FMO3—vagina—urinary bladder cancer	0.00228	0.0331	CbGeAlD
Voriconazole—FMO1—lymph node—urinary bladder cancer	0.00171	0.0248	CbGeAlD
Voriconazole—CYP3A5—prostate gland—urinary bladder cancer	0.00161	0.0233	CbGeAlD
Voriconazole—FMO3—lymph node—urinary bladder cancer	0.00148	0.0214	CbGeAlD
Voriconazole—PTGS1—prostate gland—urinary bladder cancer	0.00144	0.021	CbGeAlD
Voriconazole—PTGS1—seminal vesicle—urinary bladder cancer	0.00122	0.0177	CbGeAlD
Voriconazole—CYP3A5—renal system—urinary bladder cancer	0.0011	0.0159	CbGeAlD
Voriconazole—CYP2B6—renal system—urinary bladder cancer	0.00109	0.0158	CbGeAlD
Voriconazole—PTGS1—epithelium—urinary bladder cancer	0.00106	0.0154	CbGeAlD
Voriconazole—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00102	0.0148	CbGeAlD
Voriconazole—CYP2C19—vagina—urinary bladder cancer	0.00101	0.0146	CbGeAlD
Voriconazole—PTGS1—renal system—urinary bladder cancer	0.000985	0.0143	CbGeAlD
Voriconazole—CYP2B6—female reproductive system—urinary bladder cancer	0.000872	0.0127	CbGeAlD
Voriconazole—CYP2C9—female reproductive system—urinary bladder cancer	0.000864	0.0125	CbGeAlD
Voriconazole—CYP3A4—renal system—urinary bladder cancer	0.000823	0.0119	CbGeAlD
Voriconazole—CYP3A5—vagina—urinary bladder cancer	0.000794	0.0115	CbGeAlD
Voriconazole—CYP2B6—vagina—urinary bladder cancer	0.000789	0.0115	CbGeAlD
Voriconazole—PTGS1—female reproductive system—urinary bladder cancer	0.000789	0.0114	CbGeAlD
Voriconazole—PTGS1—vagina—urinary bladder cancer	0.000713	0.0104	CbGeAlD
Voriconazole—CYP3A4—female reproductive system—urinary bladder cancer	0.000659	0.00956	CbGeAlD
Voriconazole—PTGS1—lymph node—urinary bladder cancer	0.000461	0.0067	CbGeAlD
Voriconazole—Haematuria—Doxorubicin—urinary bladder cancer	0.000108	0.000303	CcSEcCtD
Voriconazole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000108	0.000303	CcSEcCtD
Voriconazole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000108	0.000302	CcSEcCtD
Voriconazole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000107	0.0003	CcSEcCtD
Voriconazole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000107	0.0003	CcSEcCtD
Voriconazole—Angiopathy—Methotrexate—urinary bladder cancer	0.000107	0.000299	CcSEcCtD
Voriconazole—Sinusitis—Doxorubicin—urinary bladder cancer	0.000106	0.000298	CcSEcCtD
Voriconazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000106	0.000297	CcSEcCtD
Voriconazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000106	0.000297	CcSEcCtD
Voriconazole—Visual impairment—Epirubicin—urinary bladder cancer	0.000106	0.000297	CcSEcCtD
Voriconazole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000106	0.000297	CcSEcCtD
Voriconazole—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000106	0.000296	CcSEcCtD
Voriconazole—Chills—Methotrexate—urinary bladder cancer	0.000105	0.000295	CcSEcCtD
Voriconazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000104	0.000292	CcSEcCtD
Voriconazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000104	0.000291	CcSEcCtD
Voriconazole—Alopecia—Methotrexate—urinary bladder cancer	0.000104	0.000291	CcSEcCtD
Voriconazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000104	0.000291	CcSEcCtD
Voriconazole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000104	0.00029	CcSEcCtD
Voriconazole—Mental disorder—Methotrexate—urinary bladder cancer	0.000103	0.000288	CcSEcCtD
Voriconazole—Rash—Gemcitabine—urinary bladder cancer	0.000103	0.000288	CcSEcCtD
Voriconazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000103	0.000288	CcSEcCtD
Voriconazole—Eye disorder—Epirubicin—urinary bladder cancer	0.000103	0.000288	CcSEcCtD
Voriconazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.000103	0.000288	CcSEcCtD
Voriconazole—Tinnitus—Epirubicin—urinary bladder cancer	0.000103	0.000287	CcSEcCtD
Voriconazole—Erythema—Methotrexate—urinary bladder cancer	0.000102	0.000287	CcSEcCtD
Voriconazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000102	0.000287	CcSEcCtD
Voriconazole—Headache—Gemcitabine—urinary bladder cancer	0.000102	0.000287	CcSEcCtD
Voriconazole—Flushing—Epirubicin—urinary bladder cancer	0.000102	0.000286	CcSEcCtD
Voriconazole—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000102	0.000286	CcSEcCtD
Voriconazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000102	0.000286	CcSEcCtD
Voriconazole—Rhinitis—Doxorubicin—urinary bladder cancer	0.000102	0.000286	CcSEcCtD
Voriconazole—Hepatitis—Doxorubicin—urinary bladder cancer	0.000102	0.000285	CcSEcCtD
Voriconazole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000101	0.000284	CcSEcCtD
Voriconazole—Rash—Fluorouracil—urinary bladder cancer	0.000101	0.000284	CcSEcCtD
Voriconazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000101	0.000283	CcSEcCtD
Voriconazole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000101	0.000283	CcSEcCtD
Voriconazole—Headache—Fluorouracil—urinary bladder cancer	0.000101	0.000282	CcSEcCtD
Voriconazole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.0001	0.000282	CcSEcCtD
Voriconazole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.0001	0.000281	CcSEcCtD
Voriconazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.0001	0.000281	CcSEcCtD
Voriconazole—Asthenia—Etoposide—urinary bladder cancer	0.0001	0.00028	CcSEcCtD
Voriconazole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.0001	0.00028	CcSEcCtD
Voriconazole—Angiopathy—Epirubicin—urinary bladder cancer	9.98e-05	0.00028	CcSEcCtD
Voriconazole—Urethral disorder—Doxorubicin—urinary bladder cancer	9.97e-05	0.000279	CcSEcCtD
Voriconazole—Immune system disorder—Epirubicin—urinary bladder cancer	9.93e-05	0.000278	CcSEcCtD
Voriconazole—Mediastinal disorder—Epirubicin—urinary bladder cancer	9.91e-05	0.000278	CcSEcCtD
Voriconazole—Back pain—Methotrexate—urinary bladder cancer	9.89e-05	0.000277	CcSEcCtD
Voriconazole—Chills—Epirubicin—urinary bladder cancer	9.87e-05	0.000276	CcSEcCtD
Voriconazole—Pruritus—Etoposide—urinary bladder cancer	9.86e-05	0.000276	CcSEcCtD
Voriconazole—Arrhythmia—Epirubicin—urinary bladder cancer	9.82e-05	0.000275	CcSEcCtD
Voriconazole—Visual impairment—Doxorubicin—urinary bladder cancer	9.81e-05	0.000275	CcSEcCtD
Voriconazole—Alopecia—Epirubicin—urinary bladder cancer	9.72e-05	0.000272	CcSEcCtD
Voriconazole—Nausea—Gemcitabine—urinary bladder cancer	9.7e-05	0.000272	CcSEcCtD
Voriconazole—Vomiting—Cisplatin—urinary bladder cancer	9.67e-05	0.000271	CcSEcCtD
Voriconazole—Vision blurred—Methotrexate—urinary bladder cancer	9.64e-05	0.00027	CcSEcCtD
Voriconazole—Mental disorder—Epirubicin—urinary bladder cancer	9.63e-05	0.00027	CcSEcCtD
Voriconazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	9.62e-05	0.00027	CcSEcCtD
Voriconazole—Rash—Cisplatin—urinary bladder cancer	9.59e-05	0.000269	CcSEcCtD
Voriconazole—Dermatitis—Cisplatin—urinary bladder cancer	9.58e-05	0.000269	CcSEcCtD
Voriconazole—Malnutrition—Epirubicin—urinary bladder cancer	9.57e-05	0.000268	CcSEcCtD
Voriconazole—Erythema—Epirubicin—urinary bladder cancer	9.57e-05	0.000268	CcSEcCtD
Voriconazole—Diarrhoea—Etoposide—urinary bladder cancer	9.54e-05	0.000267	CcSEcCtD
Voriconazole—Nausea—Fluorouracil—urinary bladder cancer	9.53e-05	0.000267	CcSEcCtD
Voriconazole—Eye disorder—Doxorubicin—urinary bladder cancer	9.51e-05	0.000266	CcSEcCtD
Voriconazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	9.49e-05	0.000266	CcSEcCtD
Voriconazole—Tinnitus—Doxorubicin—urinary bladder cancer	9.49e-05	0.000266	CcSEcCtD
Voriconazole—Anaemia—Methotrexate—urinary bladder cancer	9.45e-05	0.000265	CcSEcCtD
Voriconazole—Flushing—Doxorubicin—urinary bladder cancer	9.44e-05	0.000265	CcSEcCtD
Voriconazole—Cardiac disorder—Doxorubicin—urinary bladder cancer	9.44e-05	0.000265	CcSEcCtD
Voriconazole—Flatulence—Epirubicin—urinary bladder cancer	9.43e-05	0.000264	CcSEcCtD
Voriconazole—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.41e-05	0.000654	CbGpPWpGaD
Voriconazole—Dysgeusia—Epirubicin—urinary bladder cancer	9.37e-05	0.000263	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	9.34e-05	0.00065	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GSTT1—urinary bladder cancer	9.3e-05	0.000647	CbGpPWpGaD
Voriconazole—Back pain—Epirubicin—urinary bladder cancer	9.26e-05	0.000259	CcSEcCtD
Voriconazole—Angiopathy—Doxorubicin—urinary bladder cancer	9.23e-05	0.000259	CcSEcCtD
Voriconazole—Malaise—Methotrexate—urinary bladder cancer	9.22e-05	0.000258	CcSEcCtD
Voriconazole—Dizziness—Etoposide—urinary bladder cancer	9.22e-05	0.000258	CcSEcCtD
Voriconazole—Muscle spasms—Epirubicin—urinary bladder cancer	9.2e-05	0.000258	CcSEcCtD
Voriconazole—Immune system disorder—Doxorubicin—urinary bladder cancer	9.19e-05	0.000258	CcSEcCtD
Voriconazole—Vertigo—Methotrexate—urinary bladder cancer	9.19e-05	0.000258	CcSEcCtD
Voriconazole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	9.17e-05	0.000257	CcSEcCtD
Voriconazole—Leukopenia—Methotrexate—urinary bladder cancer	9.16e-05	0.000257	CcSEcCtD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.15e-05	0.000637	CbGpPWpGaD
Voriconazole—Chills—Doxorubicin—urinary bladder cancer	9.13e-05	0.000256	CcSEcCtD
Voriconazole—Arrhythmia—Doxorubicin—urinary bladder cancer	9.09e-05	0.000255	CcSEcCtD
Voriconazole—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.06e-05	0.00063	CbGpPWpGaD
Voriconazole—Nausea—Cisplatin—urinary bladder cancer	9.04e-05	0.000253	CcSEcCtD
Voriconazole—Vision blurred—Epirubicin—urinary bladder cancer	9.02e-05	0.000253	CcSEcCtD
Voriconazole—FMO1—Metabolism—GSTP1—urinary bladder cancer	9.01e-05	0.000627	CbGpPWpGaD
Voriconazole—Alopecia—Doxorubicin—urinary bladder cancer	8.99e-05	0.000252	CcSEcCtD
Voriconazole—Cough—Methotrexate—urinary bladder cancer	8.93e-05	0.00025	CcSEcCtD
Voriconazole—Mental disorder—Doxorubicin—urinary bladder cancer	8.91e-05	0.00025	CcSEcCtD
Voriconazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	8.88e-05	0.000249	CcSEcCtD
Voriconazole—Convulsion—Methotrexate—urinary bladder cancer	8.86e-05	0.000248	CcSEcCtD
Voriconazole—Vomiting—Etoposide—urinary bladder cancer	8.86e-05	0.000248	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	8.86e-05	0.000616	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NAT1—urinary bladder cancer	8.86e-05	0.000616	CbGpPWpGaD
Voriconazole—Erythema—Doxorubicin—urinary bladder cancer	8.86e-05	0.000248	CcSEcCtD
Voriconazole—Malnutrition—Doxorubicin—urinary bladder cancer	8.86e-05	0.000248	CcSEcCtD
Voriconazole—Anaemia—Epirubicin—urinary bladder cancer	8.85e-05	0.000248	CcSEcCtD
Voriconazole—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	8.84e-05	0.000615	CbGpPWpGaD
Voriconazole—Agitation—Epirubicin—urinary bladder cancer	8.8e-05	0.000247	CcSEcCtD
Voriconazole—Rash—Etoposide—urinary bladder cancer	8.79e-05	0.000246	CcSEcCtD
Voriconazole—Dermatitis—Etoposide—urinary bladder cancer	8.78e-05	0.000246	CcSEcCtD
Voriconazole—Headache—Etoposide—urinary bladder cancer	8.73e-05	0.000245	CcSEcCtD
Voriconazole—Flatulence—Doxorubicin—urinary bladder cancer	8.73e-05	0.000245	CcSEcCtD
Voriconazole—Myalgia—Methotrexate—urinary bladder cancer	8.71e-05	0.000244	CcSEcCtD
Voriconazole—Chest pain—Methotrexate—urinary bladder cancer	8.71e-05	0.000244	CcSEcCtD
Voriconazole—Arthralgia—Methotrexate—urinary bladder cancer	8.71e-05	0.000244	CcSEcCtD
Voriconazole—Dysgeusia—Doxorubicin—urinary bladder cancer	8.67e-05	0.000243	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	8.65e-05	0.000242	CcSEcCtD
Voriconazole—Malaise—Epirubicin—urinary bladder cancer	8.63e-05	0.000242	CcSEcCtD
Voriconazole—Discomfort—Methotrexate—urinary bladder cancer	8.6e-05	0.000241	CcSEcCtD
Voriconazole—Vertigo—Epirubicin—urinary bladder cancer	8.6e-05	0.000241	CcSEcCtD
Voriconazole—PTGS1—Metabolism—GSTO2—urinary bladder cancer	8.59e-05	0.000597	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NAT1—urinary bladder cancer	8.59e-05	0.000597	CbGpPWpGaD
Voriconazole—Syncope—Epirubicin—urinary bladder cancer	8.58e-05	0.000241	CcSEcCtD
Voriconazole—Leukopenia—Epirubicin—urinary bladder cancer	8.57e-05	0.00024	CcSEcCtD
Voriconazole—Back pain—Doxorubicin—urinary bladder cancer	8.57e-05	0.00024	CcSEcCtD
Voriconazole—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	8.52e-05	0.000593	CbGpPWpGaD
Voriconazole—Muscle spasms—Doxorubicin—urinary bladder cancer	8.52e-05	0.000239	CcSEcCtD
Voriconazole—Palpitations—Epirubicin—urinary bladder cancer	8.46e-05	0.000237	CcSEcCtD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.45e-05	0.000587	CbGpPWpGaD
Voriconazole—Confusional state—Methotrexate—urinary bladder cancer	8.42e-05	0.000236	CcSEcCtD
Voriconazole—Loss of consciousness—Epirubicin—urinary bladder cancer	8.41e-05	0.000236	CcSEcCtD
Voriconazole—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.41e-05	0.000585	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—TYMS—urinary bladder cancer	8.38e-05	0.000583	CbGpPWpGaD
Voriconazole—Cough—Epirubicin—urinary bladder cancer	8.35e-05	0.000234	CcSEcCtD
Voriconazole—Anaphylactic shock—Methotrexate—urinary bladder cancer	8.35e-05	0.000234	CcSEcCtD
Voriconazole—Vision blurred—Doxorubicin—urinary bladder cancer	8.35e-05	0.000234	CcSEcCtD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.35e-05	0.000581	CbGpPWpGaD
Voriconazole—Convulsion—Epirubicin—urinary bladder cancer	8.29e-05	0.000232	CcSEcCtD
Voriconazole—Infection—Methotrexate—urinary bladder cancer	8.29e-05	0.000232	CcSEcCtD
Voriconazole—FMO1—Metabolism—GSTM1—urinary bladder cancer	8.28e-05	0.000576	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—NCOR1—urinary bladder cancer	8.28e-05	0.000576	CbGpPWpGaD
Voriconazole—Nausea—Etoposide—urinary bladder cancer	8.28e-05	0.000232	CcSEcCtD
Voriconazole—Hypertension—Epirubicin—urinary bladder cancer	8.26e-05	0.000232	CcSEcCtD
Voriconazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	8.22e-05	0.00023	CcSEcCtD
Voriconazole—Nervous system disorder—Methotrexate—urinary bladder cancer	8.19e-05	0.000229	CcSEcCtD
Voriconazole—Anaemia—Doxorubicin—urinary bladder cancer	8.19e-05	0.000229	CcSEcCtD
Voriconazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	8.17e-05	0.000229	CcSEcCtD
Voriconazole—Arthralgia—Epirubicin—urinary bladder cancer	8.15e-05	0.000228	CcSEcCtD
Voriconazole—Chest pain—Epirubicin—urinary bladder cancer	8.15e-05	0.000228	CcSEcCtD
Voriconazole—Myalgia—Epirubicin—urinary bladder cancer	8.15e-05	0.000228	CcSEcCtD
Voriconazole—Agitation—Doxorubicin—urinary bladder cancer	8.14e-05	0.000228	CcSEcCtD
Voriconazole—Anxiety—Epirubicin—urinary bladder cancer	8.12e-05	0.000228	CcSEcCtD
Voriconazole—Skin disorder—Methotrexate—urinary bladder cancer	8.11e-05	0.000227	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	8.1e-05	0.000563	CbGpPWpGaD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	8.09e-05	0.000227	CcSEcCtD
Voriconazole—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.07e-05	0.000226	CcSEcCtD
Voriconazole—Discomfort—Epirubicin—urinary bladder cancer	8.05e-05	0.000226	CcSEcCtD
Voriconazole—Malaise—Doxorubicin—urinary bladder cancer	7.99e-05	0.000224	CcSEcCtD
Voriconazole—Dry mouth—Epirubicin—urinary bladder cancer	7.97e-05	0.000223	CcSEcCtD
Voriconazole—Vertigo—Doxorubicin—urinary bladder cancer	7.96e-05	0.000223	CcSEcCtD
Voriconazole—Anorexia—Methotrexate—urinary bladder cancer	7.96e-05	0.000223	CcSEcCtD
Voriconazole—Syncope—Doxorubicin—urinary bladder cancer	7.94e-05	0.000223	CcSEcCtD
Voriconazole—FMO1—Metabolism—GPX1—urinary bladder cancer	7.93e-05	0.000552	CbGpPWpGaD
Voriconazole—Leukopenia—Doxorubicin—urinary bladder cancer	7.93e-05	0.000222	CcSEcCtD
Voriconazole—Confusional state—Epirubicin—urinary bladder cancer	7.88e-05	0.000221	CcSEcCtD
Voriconazole—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	7.85e-05	0.000546	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	7.83e-05	0.000545	CbGpPWpGaD
Voriconazole—Palpitations—Doxorubicin—urinary bladder cancer	7.83e-05	0.000219	CcSEcCtD
Voriconazole—Oedema—Epirubicin—urinary bladder cancer	7.81e-05	0.000219	CcSEcCtD
Voriconazole—Anaphylactic shock—Epirubicin—urinary bladder cancer	7.81e-05	0.000219	CcSEcCtD
Voriconazole—Hypotension—Methotrexate—urinary bladder cancer	7.8e-05	0.000219	CcSEcCtD
Voriconazole—FMO1—Metabolism—ERCC2—urinary bladder cancer	7.79e-05	0.000542	CbGpPWpGaD
Voriconazole—Loss of consciousness—Doxorubicin—urinary bladder cancer	7.79e-05	0.000218	CcSEcCtD
Voriconazole—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	7.77e-05	0.000541	CbGpPWpGaD
Voriconazole—Infection—Epirubicin—urinary bladder cancer	7.76e-05	0.000217	CcSEcCtD
Voriconazole—Cough—Doxorubicin—urinary bladder cancer	7.73e-05	0.000217	CcSEcCtD
Voriconazole—FMO3—Metabolism—NQO1—urinary bladder cancer	7.73e-05	0.000537	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.73e-05	0.000537	CbGpPWpGaD
Voriconazole—Shock—Epirubicin—urinary bladder cancer	7.69e-05	0.000215	CcSEcCtD
Voriconazole—Convulsion—Doxorubicin—urinary bladder cancer	7.67e-05	0.000215	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.67e-05	0.000533	CbGpPWpGaD
Voriconazole—Nervous system disorder—Epirubicin—urinary bladder cancer	7.66e-05	0.000215	CcSEcCtD
Voriconazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	7.65e-05	0.000214	CcSEcCtD
Voriconazole—Hypertension—Doxorubicin—urinary bladder cancer	7.65e-05	0.000214	CcSEcCtD
Voriconazole—Tachycardia—Epirubicin—urinary bladder cancer	7.63e-05	0.000214	CcSEcCtD
Voriconazole—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.62e-05	0.00053	CbGpPWpGaD
Voriconazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	7.61e-05	0.000213	CcSEcCtD
Voriconazole—Skin disorder—Epirubicin—urinary bladder cancer	7.59e-05	0.000213	CcSEcCtD
Voriconazole—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.55e-05	0.000212	CcSEcCtD
Voriconazole—Insomnia—Methotrexate—urinary bladder cancer	7.55e-05	0.000212	CcSEcCtD
Voriconazole—Arthralgia—Doxorubicin—urinary bladder cancer	7.54e-05	0.000211	CcSEcCtD
Voriconazole—Chest pain—Doxorubicin—urinary bladder cancer	7.54e-05	0.000211	CcSEcCtD
Voriconazole—Myalgia—Doxorubicin—urinary bladder cancer	7.54e-05	0.000211	CcSEcCtD
Voriconazole—Anxiety—Doxorubicin—urinary bladder cancer	7.51e-05	0.000211	CcSEcCtD
Voriconazole—Paraesthesia—Methotrexate—urinary bladder cancer	7.5e-05	0.00021	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	7.49e-05	0.00021	CcSEcCtD
Voriconazole—Discomfort—Doxorubicin—urinary bladder cancer	7.45e-05	0.000209	CcSEcCtD
Voriconazole—Anorexia—Epirubicin—urinary bladder cancer	7.45e-05	0.000209	CcSEcCtD
Voriconazole—Dyspnoea—Methotrexate—urinary bladder cancer	7.44e-05	0.000209	CcSEcCtD
Voriconazole—Somnolence—Methotrexate—urinary bladder cancer	7.42e-05	0.000208	CcSEcCtD
Voriconazole—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.4e-05	0.000514	CbGpPWpGaD
Voriconazole—Dry mouth—Doxorubicin—urinary bladder cancer	7.37e-05	0.000207	CcSEcCtD
Voriconazole—Dyspepsia—Methotrexate—urinary bladder cancer	7.35e-05	0.000206	CcSEcCtD
Voriconazole—FMO1—Metabolism—MTHFR—urinary bladder cancer	7.32e-05	0.000509	CbGpPWpGaD
Voriconazole—Hypotension—Epirubicin—urinary bladder cancer	7.3e-05	0.000205	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	7.29e-05	0.000507	CbGpPWpGaD
Voriconazole—Confusional state—Doxorubicin—urinary bladder cancer	7.29e-05	0.000204	CcSEcCtD
Voriconazole—Decreased appetite—Methotrexate—urinary bladder cancer	7.26e-05	0.000203	CcSEcCtD
Voriconazole—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.23e-05	0.000203	CcSEcCtD
Voriconazole—Oedema—Doxorubicin—urinary bladder cancer	7.23e-05	0.000203	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	7.21e-05	0.000202	CcSEcCtD
Voriconazole—Infection—Doxorubicin—urinary bladder cancer	7.18e-05	0.000201	CcSEcCtD
Voriconazole—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	7.14e-05	0.000497	CbGpPWpGaD
Voriconazole—Pain—Methotrexate—urinary bladder cancer	7.14e-05	0.0002	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.12e-05	0.000199	CcSEcCtD
Voriconazole—Shock—Doxorubicin—urinary bladder cancer	7.11e-05	0.000199	CcSEcCtD
Voriconazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	7.09e-05	0.000199	CcSEcCtD
Voriconazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	7.08e-05	0.000198	CcSEcCtD
Voriconazole—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.07e-05	0.000492	CbGpPWpGaD
Voriconazole—Insomnia—Epirubicin—urinary bladder cancer	7.07e-05	0.000198	CcSEcCtD
Voriconazole—Tachycardia—Doxorubicin—urinary bladder cancer	7.06e-05	0.000198	CcSEcCtD
Voriconazole—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.04e-05	0.00049	CbGpPWpGaD
Voriconazole—Skin disorder—Doxorubicin—urinary bladder cancer	7.02e-05	0.000197	CcSEcCtD
Voriconazole—Paraesthesia—Epirubicin—urinary bladder cancer	7.02e-05	0.000197	CcSEcCtD
Voriconazole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	6.99e-05	0.000196	CcSEcCtD
Voriconazole—Dyspnoea—Epirubicin—urinary bladder cancer	6.97e-05	0.000195	CcSEcCtD
Voriconazole—Somnolence—Epirubicin—urinary bladder cancer	6.95e-05	0.000195	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	6.91e-05	0.000481	CbGpPWpGaD
Voriconazole—Anorexia—Doxorubicin—urinary bladder cancer	6.89e-05	0.000193	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	6.89e-05	0.000479	CbGpPWpGaD
Voriconazole—Feeling abnormal—Methotrexate—urinary bladder cancer	6.88e-05	0.000193	CcSEcCtD
Voriconazole—Dyspepsia—Epirubicin—urinary bladder cancer	6.88e-05	0.000193	CcSEcCtD
Voriconazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	6.83e-05	0.000191	CcSEcCtD
Voriconazole—Decreased appetite—Epirubicin—urinary bladder cancer	6.79e-05	0.00019	CcSEcCtD
Voriconazole—Hypotension—Doxorubicin—urinary bladder cancer	6.75e-05	0.000189	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	6.75e-05	0.00047	CbGpPWpGaD
Voriconazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	6.75e-05	0.000189	CcSEcCtD
Voriconazole—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	6.71e-05	0.000467	CbGpPWpGaD
Voriconazole—Pain—Epirubicin—urinary bladder cancer	6.68e-05	0.000187	CcSEcCtD
Voriconazole—Constipation—Epirubicin—urinary bladder cancer	6.68e-05	0.000187	CcSEcCtD
Voriconazole—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.68e-05	0.000464	CbGpPWpGaD
Voriconazole—Urticaria—Methotrexate—urinary bladder cancer	6.63e-05	0.000186	CcSEcCtD
Voriconazole—Abdominal pain—Methotrexate—urinary bladder cancer	6.6e-05	0.000185	CcSEcCtD
Voriconazole—Body temperature increased—Methotrexate—urinary bladder cancer	6.6e-05	0.000185	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.59e-05	0.000185	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—NAT1—urinary bladder cancer	6.55e-05	0.000456	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	6.55e-05	0.000456	CbGpPWpGaD
Voriconazole—Insomnia—Doxorubicin—urinary bladder cancer	6.54e-05	0.000183	CcSEcCtD
Voriconazole—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.51e-05	0.000453	CbGpPWpGaD
Voriconazole—Paraesthesia—Doxorubicin—urinary bladder cancer	6.49e-05	0.000182	CcSEcCtD
Voriconazole—Dyspnoea—Doxorubicin—urinary bladder cancer	6.44e-05	0.000181	CcSEcCtD
Voriconazole—FMO3—Metabolism—GSTP1—urinary bladder cancer	6.44e-05	0.000448	CbGpPWpGaD
Voriconazole—Feeling abnormal—Epirubicin—urinary bladder cancer	6.44e-05	0.00018	CcSEcCtD
Voriconazole—Somnolence—Doxorubicin—urinary bladder cancer	6.43e-05	0.00018	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—NAT1—urinary bladder cancer	6.4e-05	0.000445	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	6.4e-05	0.000445	CbGpPWpGaD
Voriconazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.39e-05	0.000179	CcSEcCtD
Voriconazole—Dyspepsia—Doxorubicin—urinary bladder cancer	6.36e-05	0.000178	CcSEcCtD
Voriconazole—Decreased appetite—Doxorubicin—urinary bladder cancer	6.28e-05	0.000176	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	6.24e-05	0.000175	CcSEcCtD
Voriconazole—Urticaria—Epirubicin—urinary bladder cancer	6.21e-05	0.000174	CcSEcCtD
Voriconazole—Pain—Doxorubicin—urinary bladder cancer	6.18e-05	0.000173	CcSEcCtD
Voriconazole—Constipation—Doxorubicin—urinary bladder cancer	6.18e-05	0.000173	CcSEcCtD
Voriconazole—Body temperature increased—Epirubicin—urinary bladder cancer	6.18e-05	0.000173	CcSEcCtD
Voriconazole—Abdominal pain—Epirubicin—urinary bladder cancer	6.18e-05	0.000173	CcSEcCtD
Voriconazole—Hypersensitivity—Methotrexate—urinary bladder cancer	6.15e-05	0.000172	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	5.99e-05	0.000417	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—TYMS—urinary bladder cancer	5.99e-05	0.000417	CbGpPWpGaD
Voriconazole—Asthenia—Methotrexate—urinary bladder cancer	5.99e-05	0.000168	CcSEcCtD
Voriconazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.96e-05	0.000167	CcSEcCtD
Voriconazole—FMO1—Metabolism—PPARG—urinary bladder cancer	5.94e-05	0.000413	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GSTM1—urinary bladder cancer	5.92e-05	0.000412	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NCOR1—urinary bladder cancer	5.92e-05	0.000412	CbGpPWpGaD
Voriconazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.91e-05	0.000166	CcSEcCtD
Voriconazole—Pruritus—Methotrexate—urinary bladder cancer	5.91e-05	0.000166	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	5.86e-05	0.000407	CbGpPWpGaD
Voriconazole—Hypersensitivity—Epirubicin—urinary bladder cancer	5.76e-05	0.000161	CcSEcCtD
Voriconazole—Urticaria—Doxorubicin—urinary bladder cancer	5.74e-05	0.000161	CcSEcCtD
Voriconazole—Abdominal pain—Doxorubicin—urinary bladder cancer	5.71e-05	0.00016	CcSEcCtD
Voriconazole—Body temperature increased—Doxorubicin—urinary bladder cancer	5.71e-05	0.00016	CcSEcCtD
Voriconazole—Diarrhoea—Methotrexate—urinary bladder cancer	5.71e-05	0.00016	CcSEcCtD
Voriconazole—FMO1—Metabolism—CREBBP—urinary bladder cancer	5.7e-05	0.000397	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GPX1—urinary bladder cancer	5.67e-05	0.000394	CbGpPWpGaD
Voriconazole—Asthenia—Epirubicin—urinary bladder cancer	5.61e-05	0.000157	CcSEcCtD
Voriconazole—FMO3—Metabolism—ERCC2—urinary bladder cancer	5.57e-05	0.000387	CbGpPWpGaD
Voriconazole—Pruritus—Epirubicin—urinary bladder cancer	5.53e-05	0.000155	CcSEcCtD
Voriconazole—Dizziness—Methotrexate—urinary bladder cancer	5.52e-05	0.000155	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	5.39e-05	0.000375	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—TYMP—urinary bladder cancer	5.37e-05	0.000373	CbGpPWpGaD
Voriconazole—Diarrhoea—Epirubicin—urinary bladder cancer	5.35e-05	0.00015	CcSEcCtD
Voriconazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.33e-05	0.000149	CcSEcCtD
Voriconazole—Vomiting—Methotrexate—urinary bladder cancer	5.31e-05	0.000149	CcSEcCtD
Voriconazole—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	5.27e-05	0.000367	CbGpPWpGaD
Voriconazole—Rash—Methotrexate—urinary bladder cancer	5.26e-05	0.000147	CcSEcCtD
Voriconazole—Dermatitis—Methotrexate—urinary bladder cancer	5.26e-05	0.000147	CcSEcCtD
Voriconazole—FMO3—Metabolism—MTHFR—urinary bladder cancer	5.23e-05	0.000364	CbGpPWpGaD
Voriconazole—Headache—Methotrexate—urinary bladder cancer	5.23e-05	0.000147	CcSEcCtD
Voriconazole—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.22e-05	0.000363	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.22e-05	0.000363	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.2e-05	0.000362	CbGpPWpGaD
Voriconazole—Asthenia—Doxorubicin—urinary bladder cancer	5.19e-05	0.000145	CcSEcCtD
Voriconazole—Dizziness—Epirubicin—urinary bladder cancer	5.17e-05	0.000145	CcSEcCtD
Voriconazole—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.13e-05	0.000357	CbGpPWpGaD
Voriconazole—Pruritus—Doxorubicin—urinary bladder cancer	5.11e-05	0.000143	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	5.09e-05	0.000354	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.06e-05	0.000352	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5e-05	0.000347	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	4.98e-05	0.000346	CbGpPWpGaD
Voriconazole—Vomiting—Epirubicin—urinary bladder cancer	4.97e-05	0.000139	CcSEcCtD
Voriconazole—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	4.96e-05	0.000345	CbGpPWpGaD
Voriconazole—Nausea—Methotrexate—urinary bladder cancer	4.96e-05	0.000139	CcSEcCtD
Voriconazole—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	4.95e-05	0.000344	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NAT1—urinary bladder cancer	4.95e-05	0.000344	CbGpPWpGaD
Voriconazole—Diarrhoea—Doxorubicin—urinary bladder cancer	4.95e-05	0.000139	CcSEcCtD
Voriconazole—Rash—Epirubicin—urinary bladder cancer	4.93e-05	0.000138	CcSEcCtD
Voriconazole—Dermatitis—Epirubicin—urinary bladder cancer	4.92e-05	0.000138	CcSEcCtD
Voriconazole—Headache—Epirubicin—urinary bladder cancer	4.89e-05	0.000137	CcSEcCtD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.87e-05	0.000339	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NAT2—urinary bladder cancer	4.85e-05	0.000338	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	4.85e-05	0.000338	CbGpPWpGaD
Voriconazole—Dizziness—Doxorubicin—urinary bladder cancer	4.78e-05	0.000134	CcSEcCtD
Voriconazole—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.76e-05	0.000331	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.71e-05	0.000328	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.7e-05	0.000327	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTGS2—urinary bladder cancer	4.67e-05	0.000325	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.65e-05	0.000323	CbGpPWpGaD
Voriconazole—Nausea—Epirubicin—urinary bladder cancer	4.64e-05	0.00013	CcSEcCtD
Voriconazole—Vomiting—Doxorubicin—urinary bladder cancer	4.6e-05	0.000129	CcSEcCtD
Voriconazole—Rash—Doxorubicin—urinary bladder cancer	4.56e-05	0.000128	CcSEcCtD
Voriconazole—Dermatitis—Doxorubicin—urinary bladder cancer	4.55e-05	0.000128	CcSEcCtD
Voriconazole—Headache—Doxorubicin—urinary bladder cancer	4.53e-05	0.000127	CcSEcCtD
Voriconazole—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.53e-05	0.000315	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.51e-05	0.000314	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.51e-05	0.000314	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.44e-05	0.000309	CbGpPWpGaD
Voriconazole—Nausea—Doxorubicin—urinary bladder cancer	4.29e-05	0.00012	CcSEcCtD
Voriconazole—FMO3—Metabolism—PPARG—urinary bladder cancer	4.24e-05	0.000295	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—RRM2—urinary bladder cancer	4.19e-05	0.000291	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.13e-05	0.000287	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CREBBP—urinary bladder cancer	4.08e-05	0.000284	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.08e-05	0.000284	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTEN—urinary bladder cancer	4.07e-05	0.000283	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.06e-05	0.000282	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.97e-05	0.000276	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—EP300—urinary bladder cancer	3.88e-05	0.00027	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	3.88e-05	0.00027	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—ENO2—urinary bladder cancer	3.88e-05	0.00027	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.88e-05	0.00027	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.85e-05	0.000268	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	3.76e-05	0.000262	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.76e-05	0.000262	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.76e-05	0.000262	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.75e-05	0.000261	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.74e-05	0.00026	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.72e-05	0.000259	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.65e-05	0.000254	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.59e-05	0.00025	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.59e-05	0.00025	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.51e-05	0.000244	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.51e-05	0.000244	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.42e-05	0.000238	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTGS2—urinary bladder cancer	3.34e-05	0.000232	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.14e-05	0.000218	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NQO1—urinary bladder cancer	3.13e-05	0.000218	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.1e-05	0.000215	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.03e-05	0.000211	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.03e-05	0.000211	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.01e-05	0.000209	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3e-05	0.000209	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.98e-05	0.000207	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.98e-05	0.000207	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.94e-05	0.000205	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTEN—urinary bladder cancer	2.91e-05	0.000203	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.88e-05	0.0002	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.87e-05	0.0002	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.87e-05	0.0002	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.8e-05	0.000195	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.8e-05	0.000195	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.78e-05	0.000194	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—EP300—urinary bladder cancer	2.78e-05	0.000193	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.74e-05	0.000191	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.73e-05	0.00019	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.72e-05	0.000189	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.72e-05	0.000189	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.71e-05	0.000189	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.63e-05	0.000183	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.61e-05	0.000181	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.57e-05	0.000178	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.53e-05	0.000176	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.47e-05	0.000172	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.45e-05	0.00017	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.45e-05	0.00017	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.43e-05	0.000169	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.4e-05	0.000167	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.4e-05	0.000167	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.35e-05	0.000163	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.34e-05	0.000163	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.32e-05	0.000162	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.32e-05	0.000162	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.32e-05	0.000161	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.31e-05	0.000161	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.3e-05	0.00016	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.26e-05	0.000157	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.26e-05	0.000157	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.25e-05	0.000157	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.23e-05	0.000155	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.18e-05	0.000152	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.17e-05	0.000151	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.17e-05	0.000151	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.16e-05	0.00015	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.13e-05	0.000148	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.12e-05	0.000147	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.1e-05	0.000146	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.07e-05	0.000144	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.05e-05	0.000143	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.98e-05	0.000138	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.98e-05	0.000138	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.97e-05	0.000137	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.93e-05	0.000134	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.92e-05	0.000133	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.89e-05	0.000131	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.89e-05	0.000131	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.8e-05	0.000125	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.79e-05	0.000125	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.77e-05	0.000123	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.77e-05	0.000123	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.75e-05	0.000122	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.75e-05	0.000122	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.73e-05	0.000121	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.73e-05	0.000121	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.72e-05	0.000119	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.7e-05	0.000118	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.7e-05	0.000118	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.67e-05	0.000116	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.67e-05	0.000116	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.66e-05	0.000115	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.65e-05	0.000115	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.63e-05	0.000113	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.63e-05	0.000113	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.6e-05	0.000111	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.59e-05	0.000111	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.57e-05	0.000109	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.55e-05	0.000108	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.53e-05	0.000107	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.48e-05	0.000103	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.46e-05	0.000101	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.41e-05	9.81e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.41e-05	9.79e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.36e-05	9.43e-05	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.35e-05	9.4e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.35e-05	9.38e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	9.32e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	9.32e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.33e-05	9.24e-05	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	9.11e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	9.07e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.3e-05	9.07e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.29e-05	8.94e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.28e-05	8.92e-05	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.27e-05	8.84e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	8.8e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	8.76e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.24e-05	8.64e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.24e-05	8.59e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.22e-05	8.5e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.22e-05	8.5e-05	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.22e-05	8.49e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.19e-05	8.3e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	8.23e-05	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.18e-05	8.2e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.17e-05	8.14e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.15e-05	7.99e-05	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.14e-05	7.95e-05	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.12e-05	7.82e-05	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—EP300—urinary bladder cancer	1.09e-05	7.58e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.08e-05	7.51e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.05e-05	7.31e-05	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	9.99e-06	6.95e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	9.77e-06	6.79e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.6e-06	6.68e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.22e-06	6.41e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.77e-06	6.1e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.75e-06	6.09e-05	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTEN—urinary bladder cancer	8.72e-06	6.06e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTEN—urinary bladder cancer	8.52e-06	5.93e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.41e-06	5.85e-05	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—EP300—urinary bladder cancer	8.31e-06	5.78e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.15e-06	5.67e-05	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—EP300—urinary bladder cancer	8.12e-06	5.65e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.06e-06	5.6e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.06e-06	5.6e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.71e-06	5.37e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.57e-06	5.27e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.55e-06	5.25e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.12e-06	4.95e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.89e-06	4.79e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.59e-06	4.58e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.28e-06	4.37e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.01e-06	4.18e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.77e-06	4.02e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.73e-06	3.98e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.55e-06	3.86e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.54e-06	3.16e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.96e-06	2.75e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.78e-06	2.63e-05	CbGpPWpGaD
